Role of C-reactive protein in the assessment of cardiovascular risk.
Jialal
Ishwarlal
I
Laboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center, Sacramento, California 95817, USA. ishwarlal.jialal@ucdmc.ucdavis.edu
Devaraj
Sridevi
S
D000975:Antioxidants / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000097:blood* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D009765:Obesity / Q000097:blood; D012307:Risk Factors; D015431:Weight Loss; D024502:alpha-Tocopherol / Q000627:therapeutic use
D000975:Antioxidants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002097:C-Reactive Protein; D024502:alpha-Tocopherol